183 related articles for article (PubMed ID: 15882241)
1. Polypharmacy and Crohn's disease.
Cross RK; Wilson KT; Binion DG
Aliment Pharmacol Ther; 2005 May; 21(10):1211-6. PubMed ID: 15882241
[TBL] [Abstract][Full Text] [Related]
2. Narcotic use in patients with Crohn's disease.
Cross RK; Wilson KT; Binion DG
Am J Gastroenterol; 2005 Oct; 100(10):2225-9. PubMed ID: 16181373
[TBL] [Abstract][Full Text] [Related]
3. Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion.
Kasparek MS; Glatzle J; Temeltcheva T; Mueller MH; Koenigsrainer A; Kreis ME
Dis Colon Rectum; 2007 Dec; 50(12):2067-74. PubMed ID: 17680311
[TBL] [Abstract][Full Text] [Related]
4. Enteral nutrition improves health-related quality of life in Crohn's disease patients with long disease duration.
Kuriyama M; Kato J; Morimoto N; Fujimoto T; Kono H; Okano N; Miyaike J; Morita T; Okada H; Suzuki S; Yoshioka T; Shiode J; Shiratori Y; Kazuhide Y;
Hepatogastroenterology; 2009; 56(90):321-7. PubMed ID: 19579591
[TBL] [Abstract][Full Text] [Related]
5. A 5-year prospective observational study of the outcomes of international treatment guidelines for Crohn's disease.
Cullen G; Keegan D; Mulcahy HE; O'Donoghue DP
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):323-8; quiz 252. PubMed ID: 19174193
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
Kim BC; Park S; Han J; Kim JH; Kim TI; Kim WH
Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
Plamondon S; Ng SC; Kamm MA
Aliment Pharmacol Ther; 2007 Mar; 25(5):557-67. PubMed ID: 17305756
[TBL] [Abstract][Full Text] [Related]
8. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
Thia KT; Sandborn WJ; Lewis JD; Loftus EV; Feagan BG; Steinhart AH; Hanauer SB; Persson T; Sands BE
Am J Gastroenterol; 2008 Dec; 103(12):3123-31. PubMed ID: 18786111
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and quality of life in patients with different phenotypes of Crohn's disease of the ileal pouch.
Shen B; Fazio VW; Remzi FH; Bennett AE; Lavery IC; Lopez R; Brezinski A; Sherman KK; Bambrick ML; Lashner BA
Dis Colon Rectum; 2007 Sep; 50(9):1450-9. PubMed ID: 17665259
[TBL] [Abstract][Full Text] [Related]
11. [Recurrence of Crohn's disease after surgery--causes and risks].
Mirow L; Hauenschild L; Hildebrand P; Kleemann M; Keller R; Franke C; Roblick UJ; Bruch HP; Kujath P
Zentralbl Chir; 2008 Apr; 133(2):182-7. PubMed ID: 18415909
[TBL] [Abstract][Full Text] [Related]
12. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
[TBL] [Abstract][Full Text] [Related]
13. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease.
Gibson PR; Weston AR; Shann A; Florin TH; Lawrance IC; Macrae FA; Radford-Smith G
J Gastroenterol Hepatol; 2007 Aug; 22(8):1306-12. PubMed ID: 17559375
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of infliximab on patients with short duration of Crohn's disease: a Japanese multicenter survey.
Matsumoto T; Iida M; Motoya S; Haruma K; Suzuki Y; Kobayashi K; Ito H; Miyata M; Kusunoki M; Chiba T; Yamamoto S; Hibi T
Dis Colon Rectum; 2008 Jun; 51(6):916-23. PubMed ID: 18322754
[TBL] [Abstract][Full Text] [Related]
15. Ornidazole in the treatment of active Crohn's disease: short-term results.
Triantafillidis JK; Nicolakis D; Emmanoullidis A; Antoniou A; Papatheodorou K; Cheracakis P
Ital J Gastroenterol; 1996 Jan; 28(1):10-4. PubMed ID: 8743067
[TBL] [Abstract][Full Text] [Related]
16. Sex-specific risks for pediatric onset among patients with Crohn's disease.
Montgomery SM; Wakefield AJ; Ekbom A
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):303-9. PubMed ID: 15017672
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of Cleveland Global Quality of Life (CGQL) as a novel marker of quality of life and disease activity in Crohn's disease.
Kiran RP; Delaney CP; Senagore AJ; O'Brien-Ermlich B; Mascha E; Thornton J; Fazio VW
Am J Gastroenterol; 2003 Aug; 98(8):1783-9. PubMed ID: 12907333
[TBL] [Abstract][Full Text] [Related]
18. The frequency of sister chromatid exchanges in patients with Crohn's disease and the effect of therapy with "anti-tumor necrosis factor" on this frequency.
Danalioglu A
Hepatogastroenterology; 2009; 56(91-92):729-33. PubMed ID: 19621692
[TBL] [Abstract][Full Text] [Related]
19. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
Charpignon C; Beau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
